A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. (2016)

First Author: Scott R

Attributed to: Confidence in Concept 2012 - Cambridge funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.205

Publication URI: https://www.repository.cam.ac.uk/handle/1810/256264

Type: Journal Article/Review